Most frequently reported adverse reactions in Blepharospasm trials1

Adverse Reactions

BOTOX®

Ptosis

21%

Superficial punctate keratitis

6%

Eye dryness

6%

Based on a study of Blepharospasm patients who received an average dose per eye of 33 Units (injected at 3 to 5 sites) of the currently manufactured BOTOX®.